DK0751785T4 - Kombinationer af thrombolytisk aktive proteiner og antikoagulationsmidler samt anvendelse heraf - Google Patents
Kombinationer af thrombolytisk aktive proteiner og antikoagulationsmidler samt anvendelse herafInfo
- Publication number
- DK0751785T4 DK0751785T4 DK95912261T DK95912261T DK0751785T4 DK 0751785 T4 DK0751785 T4 DK 0751785T4 DK 95912261 T DK95912261 T DK 95912261T DK 95912261 T DK95912261 T DK 95912261T DK 0751785 T4 DK0751785 T4 DK 0751785T4
- Authority
- DK
- Denmark
- Prior art keywords
- thrombolytically
- thrombolytically active
- anticoagulants
- combinations
- anticoagulant
- Prior art date
Links
- 239000003146 anticoagulant agent Substances 0.000 title abstract 6
- 229940127219 anticoagulant drug Drugs 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 2
- 229960002897 heparin Drugs 0.000 abstract 2
- 229920000669 heparin Polymers 0.000 abstract 2
- 238000009512 pharmaceutical packaging Methods 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 230000002537 thrombolytic effect Effects 0.000 abstract 2
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/217,618 US5510330A (en) | 1994-03-25 | 1994-03-25 | Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof. |
PCT/EP1995/001061 WO1995026202A1 (en) | 1994-03-25 | 1995-03-22 | Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DK0751785T3 DK0751785T3 (da) | 1999-04-06 |
DK0751785T4 true DK0751785T4 (da) | 2002-04-15 |
Family
ID=22811809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95912261T DK0751785T4 (da) | 1994-03-25 | 1995-03-22 | Kombinationer af thrombolytisk aktive proteiner og antikoagulationsmidler samt anvendelse heraf |
Country Status (21)
Country | Link |
---|---|
US (1) | US5510330A (ru) |
EP (2) | EP0751785B2 (ru) |
JP (1) | JPH09510439A (ru) |
KR (1) | KR100366982B1 (ru) |
CN (1) | CN1090029C (ru) |
AT (1) | ATE167631T1 (ru) |
AU (1) | AU702470B2 (ru) |
BR (1) | BR9507189A (ru) |
CA (1) | CA2186390A1 (ru) |
CZ (1) | CZ279596A3 (ru) |
DE (1) | DE69503120T3 (ru) |
DK (1) | DK0751785T4 (ru) |
ES (1) | ES2119411T5 (ru) |
FI (1) | FI120182B (ru) |
MX (1) | MX9603925A (ru) |
NO (1) | NO316584B1 (ru) |
NZ (1) | NZ282417A (ru) |
PL (1) | PL182165B1 (ru) |
RU (1) | RU2166326C2 (ru) |
UA (1) | UA41398C2 (ru) |
WO (1) | WO1995026202A1 (ru) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7611533B2 (en) * | 1995-06-07 | 2009-11-03 | Cook Incorporated | Coated implantable medical device |
US7550005B2 (en) * | 1995-06-07 | 2009-06-23 | Cook Incorporated | Coated implantable medical device |
US20070203520A1 (en) * | 1995-06-07 | 2007-08-30 | Dennis Griffin | Endovascular filter |
US7896914B2 (en) * | 1995-06-07 | 2011-03-01 | Cook Incorporated | Coated implantable medical device |
US7846202B2 (en) | 1995-06-07 | 2010-12-07 | Cook Incorporated | Coated implantable medical device |
US7867275B2 (en) * | 1995-06-07 | 2011-01-11 | Cook Incorporated | Coated implantable medical device method |
US6774278B1 (en) * | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
US5840733A (en) * | 1996-07-01 | 1998-11-24 | Redcell, Canada, Inc. | Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes |
US6010911A (en) * | 1997-04-30 | 2000-01-04 | Medtronic, Inc. | Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique |
US6750201B1 (en) * | 1997-10-17 | 2004-06-15 | The Trustees Of The University Of Pennsylvania | Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
US6517814B2 (en) | 2001-01-09 | 2003-02-11 | Bristol-Myers Squibb Pharma Company | Macrocyclic chelants useful for metallopharmaceuticals |
DE10115740A1 (de) * | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
DE10153601A1 (de) * | 2001-11-02 | 2003-05-22 | Paion Gmbh | DSPA zur Behandlung von Schlaganfall |
FI20020197A0 (fi) * | 2002-02-01 | 2002-02-01 | Orion Corp | Yhdistelmä akuutin myokardiilisen infarktin hoitoon |
US7084118B2 (en) * | 2002-02-22 | 2006-08-01 | Genentech, Inc. | Combination treatment with t-PA variant and low molecular weight heparin |
EP2324866B1 (en) * | 2002-07-12 | 2014-06-18 | Cook Medical Technologies LLC | Angioplasty balloons drug-coated in an expanded condition |
DE10244847A1 (de) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
ES2375064T3 (es) * | 2004-05-17 | 2012-02-24 | Medtronic, Inc. | Sistema de determinación de heparina en el lugar de atención al paciente. |
US20060222640A1 (en) * | 2005-03-29 | 2006-10-05 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions for treatment of thrombosis |
TWI482628B (zh) * | 2007-10-18 | 2015-05-01 | Lundbeck & Co As H | 新穎之血栓溶解病患次群 |
CN101952309A (zh) * | 2007-12-21 | 2011-01-19 | Ifxa有限公司 | 蛋白酶抑制剂 |
CA2966332C (en) | 2014-11-03 | 2024-04-16 | Thrombolytic Science, Llc | Methods and compositions for safe and effective thrombolysis |
KR101721068B1 (ko) * | 2015-01-30 | 2017-03-29 | 고려대학교 산학협력단 | 베르베논 유도체 및 재관류 치료제를 포함하는 뇌혈관 질환, 동맥경화증 또는 심혈관 질환 치료 또는 예방용 병용 제제 |
RU2622006C2 (ru) * | 2015-06-15 | 2017-06-08 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) федеральный университет" (ФГАОУВПО КФУ) | Применение рекомбинантного штамма bacillus subtilis eo-11 вкпм в-11978 в качестве продуцента субтилизиноподобной протеиназы, вещества с тромболитическими и антикоагулянтными свойствами |
CN105396127A (zh) * | 2015-11-13 | 2016-03-16 | 中国人民解放军第四军医大学 | 一种用于急性心肌梗死的冠状动脉溶栓剂 |
WO2018232305A1 (en) * | 2017-06-16 | 2018-12-20 | Thrombolytic Science, Llc | Methods and compositions for thrombolysis |
CN117534731A (zh) * | 2021-09-24 | 2024-02-09 | 江西康之康中药科技有限公司 | 一种抗凝血肽及其在抗凝血产品上的应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8508717D0 (en) * | 1985-04-03 | 1985-05-09 | Beecham Group Plc | Composition |
DK43387A (da) † | 1986-01-29 | 1987-07-30 | Beecham Group Plc | Fibrinolytisk enzym |
US5084274A (en) * | 1987-11-17 | 1992-01-28 | Scripps Clinic And Research Foundation | Inhibition of arterial thrombotic occlusion or thromboembolism |
DE3804600A1 (de) * | 1988-02-13 | 1989-08-24 | Basf Ag | Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz |
GB8822147D0 (en) * | 1988-09-21 | 1988-10-26 | Ciba Geigy Ag | Pharmaceutically active combination |
US5204323B1 (en) * | 1988-10-06 | 1995-07-18 | Ciba Geigy Corp | Hirudin antidotal compositions and methods |
GB8826428D0 (en) * | 1988-11-11 | 1988-12-14 | Biopharm Ltd | Antithrombin |
US4980165A (en) * | 1989-01-27 | 1990-12-25 | Genetics Institute, Inc. | Pharmaceutical formulations of plasminogen activator proteins |
DE3903581A1 (de) * | 1989-02-07 | 1990-08-16 | Boehringer Mannheim Gmbh | Gewebs-plasminogenaktivator-derivat |
EP0482069A1 (en) * | 1989-07-20 | 1992-04-29 | Biogen, Inc. | Combinations and methods for treating or preventing thrombotic diseases |
US5240913A (en) * | 1989-08-18 | 1993-08-31 | Biogen, Inc. | Inhibitors of thrombin |
US5196404B1 (en) * | 1989-08-18 | 1996-09-10 | Biogen Inc | Inhibitors of thrombin |
US5049132A (en) * | 1990-01-08 | 1991-09-17 | Cordis Corporation | Balloon catheter for delivering therapeutic agents |
US5189019A (en) * | 1990-04-23 | 1993-02-23 | Merck & Co., Inc. | Antistasin derived anticoagulant protein |
US5242810A (en) * | 1990-12-07 | 1993-09-07 | Biogen, Inc. | Bifunctional inhibitors of thrombin and platelet activation |
US5242688A (en) * | 1990-12-24 | 1993-09-07 | Eli Lilly And Company | Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants |
US5500411A (en) † | 1991-04-16 | 1996-03-19 | Boehringer Mannheim Gmbh | Method for treating thromboembolic conditions by inhibiting reocclusion via the use of multiple bolus administration of thrombolytically active proteins |
AU664469B2 (en) † | 1992-06-03 | 1995-11-16 | Genentech Inc. | Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
-
1994
- 1994-03-25 US US08/217,618 patent/US5510330A/en not_active Expired - Lifetime
-
1995
- 1995-03-22 EP EP95912261A patent/EP0751785B2/en not_active Expired - Lifetime
- 1995-03-22 KR KR1019960705381A patent/KR100366982B1/ko not_active IP Right Cessation
- 1995-03-22 AU AU19511/95A patent/AU702470B2/en not_active Ceased
- 1995-03-22 JP JP7519775A patent/JPH09510439A/ja active Pending
- 1995-03-22 CZ CZ962795A patent/CZ279596A3/cs unknown
- 1995-03-22 DK DK95912261T patent/DK0751785T4/da active
- 1995-03-22 AT AT95912261T patent/ATE167631T1/de active
- 1995-03-22 WO PCT/EP1995/001061 patent/WO1995026202A1/en not_active Application Discontinuation
- 1995-03-22 EP EP98102473A patent/EP0850648A3/en not_active Ceased
- 1995-03-22 UA UA96104031A patent/UA41398C2/ru unknown
- 1995-03-22 BR BR9507189A patent/BR9507189A/pt not_active Application Discontinuation
- 1995-03-22 MX MX9603925A patent/MX9603925A/es not_active IP Right Cessation
- 1995-03-22 ES ES95912261T patent/ES2119411T5/es not_active Expired - Lifetime
- 1995-03-22 NZ NZ282417A patent/NZ282417A/en not_active IP Right Cessation
- 1995-03-22 PL PL95316449A patent/PL182165B1/pl not_active IP Right Cessation
- 1995-03-22 DE DE69503120T patent/DE69503120T3/de not_active Expired - Lifetime
- 1995-03-22 CA CA002186390A patent/CA2186390A1/en not_active Abandoned
- 1995-03-22 RU RU96119944/14A patent/RU2166326C2/ru not_active IP Right Cessation
- 1995-03-22 CN CN95192275A patent/CN1090029C/zh not_active Expired - Fee Related
-
1996
- 1996-09-24 FI FI963802A patent/FI120182B/fi not_active IP Right Cessation
- 1996-09-24 NO NO19964007A patent/NO316584B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0751785T3 (da) | Kombinationer af thrombolytisk aktive proteiner og antikoagulationsmidler samt anvendelse heraf | |
ES2168302T3 (es) | Tratamiento de trastornos y estados neuromusculares con toxina botulinica de serotipo e. | |
DK0839026T3 (da) | Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler | |
ES2143641T3 (es) | Expresion en superficie de una enzima en la terapia genica a base de promedicamentos. | |
PT88417A (pt) | Stabilisierte humanprotein-praeparate | |
DK486588D0 (da) | Konjungater af cytokininer med immunglobuliner | |
CY1113355T1 (el) | Χρηση θεραπειας νευροτοξινης για θεραπευτικη αγωγη ουρολογικων και σχετικων διαταραχων | |
IT8819693A0 (it) | Apparecchio atto ad operare, in modo pressoche' istantaneo, la distruzione completa dell'ago di siringhe per iniezione, subito dopo il loro impiego. | |
ATE211467T1 (de) | 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung | |
DE69233760D1 (de) | Inhibitoren der menschlichen Elastase von Neutrophilen | |
FR2793678B1 (fr) | Manchon elastique a garniture viscoelastique pour la protection ou le soin de doigts ou d'orteils | |
NO972391L (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
DK0558529T3 (da) | Farmaceutisk præparat til behandling af forlænget koagulationstid | |
NO882853D0 (no) | Korreksjon med dobbeltraadet rna av unormale tilstander i immunkomplekser som er i omloep, og i monocytfunkjon. | |
ATE173627T1 (de) | Medizinische zusammensetzung | |
NO307500B1 (no) | Steril, bufret, i det vesentlige isotonisk saltvannsoppløsning | |
DE69008513D1 (de) | Pharmazeutische formulierung von plasminogenaktivatorproteinen. | |
ES2059312T3 (es) | Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion. | |
DE69417340D1 (de) | Spritze für medizinische zwecke | |
ATE187890T1 (de) | Ligandgerichtete enzyme-prodrug therapie | |
PT88539A (pt) | Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen | |
ATE143809T1 (de) | Placentaextrakt und verfahren zu seiner herstellung | |
DK491289A (da) | Modgift mod antikoaguleringsmidler | |
EA199800820A1 (ru) | Способ лечения злоупотребления лекарственными средствами | |
ES2101982T3 (es) | Composicion conteniendo una alta dosis de vitamina a. |